Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1094540

Association of Asymmetric Dimethylarginine and Nitric Oxide with Cardiovascular Risk in Patients with End-Stage Liver Disease


Dragičević, Maro; Košuta, Iva; Kruezi, Egon; Lovrenčić, Marijana Vučić; Mrzljak, Anna
Association of Asymmetric Dimethylarginine and Nitric Oxide with Cardiovascular Risk in Patients with End-Stage Liver Disease // Medicina, 56 (2020), 11; 622, 11 doi:10.3390/medicina56110622 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 1094540 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Association of Asymmetric Dimethylarginine and Nitric Oxide with Cardiovascular Risk in Patients with End-Stage Liver Disease

Autori
Dragičević, Maro ; Košuta, Iva ; Kruezi, Egon ; Lovrenčić, Marijana Vučić ; Mrzljak, Anna

Izvornik
Medicina (1010-660X) 56 (2020), 11; 622, 11

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
end-stage liver disease ; transplantation ; endothelial dysfunction ; cardiovascular risk ; asymmetric dimethylarginine ; nitric oxide

Sažetak
Background and objectives: Endothelial dysfunction has been proposed to be an underlying mechanism of the pronounced cardiovascular morbidity in end-stage liver disease (ESLD), but clinical evidence is still limited. In this study, we investigated the association of circulating levels of asymmetric dimethylarginine (ADMA) and nitric oxide (NO) with estimated cardiovascular risk in patients with ESLD awaiting liver transplantation. Materials and Methods: ADMA and NO levels were measured in the sera of 160 adult ESLD patients. The severity of hepatic dysfunction was assessed by the model for end-stage liver disease (MELD) score. The cardiovascular risk was estimated with the European Society of Cardiology Systematic Coronary Risk Estimation (SCORE) index, which was used to dichotomize patients in the subgroups depicting higher and lower cardiovascular risk. Results: Severe hepatic dysfunction (MELD ≥ 18) was present in 38% of the patients, and a higher cardiovascular risk was present in almost half of the patients (N = 74). ADMA and NO both significantly increased with the progression of liver disease and were independently associated with higher cardiovascular risk. Fasting glucose also independently predicted a higher cardiovascular risk, while HDL cholesterol and the absence of concomitant hepatocellular carcinoma were protective factors. Conclusions: These results suggest a remarkable contribution of the deranged arginine/NO pathway to cardiovascular risk in patients with end-stage liver disease.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Ustanove:
Klinička bolnica "Merkur",
Medicinski fakultet, Zagreb,
KBC "Sestre Milosrdnice",
Klinički bolnički centar Zagreb

Profili:

Avatar Url Iva Košuta (autor)

Avatar Url Anna Mrzljak (autor)

Avatar Url Egon Kruezi (autor)

Poveznice na cjeloviti tekst rada:

doi

Citiraj ovu publikaciju:

Dragičević, Maro; Košuta, Iva; Kruezi, Egon; Lovrenčić, Marijana Vučić; Mrzljak, Anna
Association of Asymmetric Dimethylarginine and Nitric Oxide with Cardiovascular Risk in Patients with End-Stage Liver Disease // Medicina, 56 (2020), 11; 622, 11 doi:10.3390/medicina56110622 (međunarodna recenzija, članak, znanstveni)
Dragičević, M., Košuta, I., Kruezi, E., Lovrenčić, M. & Mrzljak, A. (2020) Association of Asymmetric Dimethylarginine and Nitric Oxide with Cardiovascular Risk in Patients with End-Stage Liver Disease. Medicina, 56 (11), 622, 11 doi:10.3390/medicina56110622.
@article{article, author = {Dragi\v{c}evi\'{c}, Maro and Ko\v{s}uta, Iva and Kruezi, Egon and Lovren\v{c}i\'{c}, Marijana Vu\v{c}i\'{c} and Mrzljak, Anna}, year = {2020}, pages = {11}, DOI = {10.3390/medicina56110622}, chapter = {622}, keywords = {end-stage liver disease, transplantation, endothelial dysfunction, cardiovascular risk, asymmetric dimethylarginine, nitric oxide}, journal = {Medicina}, doi = {10.3390/medicina56110622}, volume = {56}, number = {11}, issn = {1010-660X}, title = {Association of Asymmetric Dimethylarginine and Nitric Oxide with Cardiovascular Risk in Patients with End-Stage Liver Disease}, keyword = {end-stage liver disease, transplantation, endothelial dysfunction, cardiovascular risk, asymmetric dimethylarginine, nitric oxide}, chapternumber = {622} }
@article{article, author = {Dragi\v{c}evi\'{c}, Maro and Ko\v{s}uta, Iva and Kruezi, Egon and Lovren\v{c}i\'{c}, Marijana Vu\v{c}i\'{c} and Mrzljak, Anna}, year = {2020}, pages = {11}, DOI = {10.3390/medicina56110622}, chapter = {622}, keywords = {end-stage liver disease, transplantation, endothelial dysfunction, cardiovascular risk, asymmetric dimethylarginine, nitric oxide}, journal = {Medicina}, doi = {10.3390/medicina56110622}, volume = {56}, number = {11}, issn = {1010-660X}, title = {Association of Asymmetric Dimethylarginine and Nitric Oxide with Cardiovascular Risk in Patients with End-Stage Liver Disease}, keyword = {end-stage liver disease, transplantation, endothelial dysfunction, cardiovascular risk, asymmetric dimethylarginine, nitric oxide}, chapternumber = {622} }

Časopis indeksira:


  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font